157 related articles for article (PubMed ID: 11831112)
1. Pharmacological treatment of insulin resistance in obesity.
Camejo G; Ljung B; Oakes N
Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):275-84. PubMed ID: 11831112
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and additional vascular effects of thiazolidinediones.
Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones--tools for the research of metabolic syndrome X.
Komers R; Vrána A
Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467
[TBL] [Abstract][Full Text] [Related]
4. Experimental approaches to study PPAR gamma agonists as antidiabetic drugs.
Vázquez M; Silvestre JS; Prous JR
Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):515-23. PubMed ID: 12500431
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
6. PPAR agonists in the treatment of insulin resistance and associated arterial disease.
Camejo G
Int J Clin Pract Suppl; 2003 Mar; (134):36-44. PubMed ID: 12793596
[TBL] [Abstract][Full Text] [Related]
7. Glitazones: clinical effects and molecular mechanisms.
Stumvoll M; Häring HU
Ann Med; 2002; 34(3):217-24. PubMed ID: 12173692
[TBL] [Abstract][Full Text] [Related]
8. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
Larsen TM; Toubro S; Astrup A
Int J Obes Relat Metab Disord; 2003 Feb; 27(2):147-61. PubMed ID: 12586994
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone: mechanism of action.
Smith U
Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
[TBL] [Abstract][Full Text] [Related]
10. [Glitazones (thiazolidinedione)].
Ducobu J; Sternon J
Rev Med Brux; 2000 Oct; 21(5):441-6. PubMed ID: 11109896
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of action of thiazolidinediones].
Girard J
Diabetes Metab; 2001 Apr; 27(2 Pt 2):271-8. PubMed ID: 11452221
[TBL] [Abstract][Full Text] [Related]
12. The mode of action of thiazolidinediones.
Hauner H
Diabetes Metab Res Rev; 2002; 18 Suppl 2():S10-5. PubMed ID: 11921433
[TBL] [Abstract][Full Text] [Related]
13. Hypertension and insulin resistance: role of peroxisome proliferator-activated receptor gamma.
Itoh H; Doi K; Tanaka T; Fukunaga Y; Hosoda K; Inoue G; Nishimura H; Yoshimasa Y; Yamori Y; Nakao K
Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):558-60. PubMed ID: 10405788
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
Sugiyama Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():416-21. PubMed ID: 12387027
[No Abstract] [Full Text] [Related]
15. Novel insulin sensitizers: pharmacogenomic aspects.
Otto C; Lehrke M; Göke B
Pharmacogenomics; 2002 Jan; 3(1):99-116. PubMed ID: 11966407
[TBL] [Abstract][Full Text] [Related]
16. Current treatment of insulin resistance in type 2 diabetes mellitus.
Tan MH
Int J Clin Pract Suppl; 2000 Oct; (113):54-62. PubMed ID: 11965833
[TBL] [Abstract][Full Text] [Related]
17. Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective.
Dumasia R; Eagle KA; Kline-Rogers E; May N; Cho L; Mukherjee D
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):377-86. PubMed ID: 16248830
[TBL] [Abstract][Full Text] [Related]
18. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
Wang M; Tafuri S
J Cell Biochem; 2003 May; 89(1):38-47. PubMed ID: 12682906
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological effects of a thiazolidinedione derivative, pioglitazone].
Ikeda H; Sugiyama Y
Nihon Rinsho; 2001 Nov; 59(11):2191-4. PubMed ID: 11712406
[TBL] [Abstract][Full Text] [Related]
20. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
